Lactobacillus sakei K040706 evokes immunostimulatory effects on macrophages through TLR 2-mediated activation

International Immunopharmacology

Volumn 28, Issue 1, 2015, Pages 88-96

  Jung, Ji Yun ^a   Shin, Ji Sun ^a,b   Lee, Suel Gie ^a   Rhee, Young Kyoung ^c   Cho, Chang Won ^c   Hong, Hee Do ^c   Lee, Kyung Tae ^a  

^a Kyung Hee University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c Korea Food Research Institute   (South Korea)

Author keywords

Cyclophosphamide; Immunostimulatory activity; Lactobacillus sakei; Macrophage; Toll like receptor 2

Indexed keywords

CYCLOPHOSPHAMIDE; I KAPPA B ALPHA; I KAPPA B BETA; IMMUNOSTIMULATING AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; MESSENGER RNA; NITRIC OXIDE; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; NOS2 PROTEIN, MOUSE; TLR2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; IMMUNE DEFICIENCY; IMMUNOSTIMULATION; INNATE IMMUNITY; LACTOBACILLUS SAKEI; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SPLEEN; THYMUS; TRANSCRIPTION INITIATION; ANIMAL; BIOSYNTHESIS; DRUG EFFECTS; IMMUNIZATION; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; LACTOBACILLUS; MACROPHAGE; METABOLISM; RAW 264.7 CELL LINE;

ANIMALS; CYCLOPHOSPHAMIDE; IMMUNIZATION; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; INTERLEUKIN-6; LACTOBACILLUS; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED ICR; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHAGOCYTOSIS; RAW 264.7 CELLS; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84930934311     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2015.05.037     Document Type: Article

References (42)

1. L.M. Prescott, J.P. Harley, and D.A. Klein 5 ed Microbiology 2003 McGraw-Hill Singapore 529 533
2. M.J. Claesson, D. van Sinderen, and P.W. O'Toole The genus Lactobacillus - a genomic basis for understanding its diversity FEMS Microbiol Lett 269 2007 22 28
3. H.S. Gill, K.J. Rutherfurd, J. Prasad, and P.K. Gopal Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019) Br J Nutr 83 2000 167 176
4. Y.T. Tsai, P.C. Cheng, C.K. Fan, and T.M. Pan Time-dependent persistence of enhanced immune response by a potential probiotic strain Lactobacillus paracasei subsp. paracasei NTU 101 Int J Food Microbiol 128 2008 219 225
5. B.R. Goldin Health benefits of probiotics Br J Nutr 80 1998 S203 S207
6. F.C. Luft Curbing the appetites of the big eaters J Mol Med (Berl) 86 2008 351 352
7. F. Balkwill Tumour necrosis factor and cancer Nat Rev Cancer 9 2009 361 371
8. M. Carini, G. Aldini, M. Orioli, A. Piccoli, G. Rossoni, and Facino R. Maffei Nitric oxide release and distribution following oral and intraperitoneal administration of nitroaspirin (NCX 4016) in the rat Life Sci 74 2004 3291 3305
9. S. Moncada, R.M. Palmer, and E.A. Higgs Nitric oxide: physiology, pathophysiology, and pharmacology Pharmacol Rev 43 1991 109 142
10. E. Vivier, D.H. Raulet, A. Moretta, M.A. Caligiuri, L. Zitvogel, and L.L. Lanier Innate or adaptive immunity? The example of natural killer cells Science 331 2011 44 49
11. C.M. Galdeano, and G. Perdigon Role of viability of probiotic strains in their persistence in the gut and in mucosal immune stimulation J Appl Microbiol 97 2004 673 681
12. G. Paturi, M. Phillips, M. Jones, and K. Kailasapathy Immune enhancing effects of Lactobacillus acidophilus LAFTI L10 and Lactobacillus paracasei LAFTI L26 in mice Int J Food Microbiol 115 2007 115 118
13. W.V. Kalina, and M. Mohamadzadeh Lactobacilli as natural enhancer of cellular immune response Discov Med 5 2005 199 203
14. O. Vaarala Immunological effects of probiotics with special reference to lactobacilli Clin Exp Allergy 33 2003 1634 1640
15. A.S. Neish The gut microflora and intestinal epithelial cells: a continuing dialogue Microbes Infect 4 2002 309 317
16. H.J. Namgung, H.J. Park, I.H. Cho, H.K. Choi, D.Y. Kwon, and S.M. Shim Metabolite profiling of doenjang, fermented soybean paste, during fermentation J Sci Food Agric 90 2010 1926 1935
17. J.Y. Kim, S.J. Park, K.J. Yun, Y.W. Cho, H.J. Park, and K.T. Lee Isoliquiritigenin isolated from the roots of Glycyrrhiza uralensis inhibits LPS-induced iNOS and COX-2 expression via the attenuation of NF-kappaB in RAW 264.7 macrophages Eur J Pharmacol 584 2008 175 184
18. E.N. Hatada, D. Krappmann, and C. Scheidereit NF-kappaB and the innate immune response Curr Opin Immunol 12 2000 52 58
19. J.L. Dean, M. Brook, A.R. Clark, and J. Saklatvala p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes J Biol Chem 274 1999 264 269
20. J.M. Wells Immunomodulatory mechanisms of lactobacilli Microb Cell Fact 10 Suppl. 1 2011 S17
21. C.M. Galdeano, and G. Perdigon The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity Clin Vaccine Immunol 13 2006 219 226
22. I.J. Claes, M.E. Segers, T.L. Verhoeven, M. Dusselier, B.F. Sels, and S.C. De Keersmaecker Lipoteichoic acid is an important microbe-associated molecular pattern of Lactobacillus rhamnosus GG Microb Cell Fact 11 2012 161
23. T. Matsuguchi, A. Takagi, T. Matsuzaki, M. Nagaoka, K. Ishikawa, and T. Yokokura Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through Toll-like receptor 2 Clin Diagn Lab Immunol 10 2003 259 266
24. Y.G. Kim, T. Ohta, T. Takahashi, A. Kushiro, K. Nomoto, and T. Yokokura Probiotic Lactobacillus casei activates innate immunity via NF-kappaB and p38 MAP kinase signaling pathways Microbes Infect 8 2006 994 1005
25. K.Y. Lee, and Y.J. Jeon Macrophage activation by polysaccharide isolated from Astragalus membranaceus Int Immunopharmacol 5 2005 1225 1233
26. H.Y. Gao, G.Y. Li, J. Huang, Y. Han, F.Z. Sun, and X.W. Du Protective effects of Zhuyeqing liquor on the immune function of normal and immunosuppressed mice in vivo BMC Complement Altern Med 13 2013 252
27. K.P. Mishra, Y.S. Padwad, M. Jain, D. Karan, L. Ganju, and R.C. Sawhney Aqueous extract of Rhodiola imbricata rhizome stimulates proinflammatory mediators via phosphorylated IkappaB and transcription factor nuclear factor-kappaB Immunopharmacol Immunotoxicol 28 2006 201 212
28. G.T. Lee, J.H. Hong, C. Kwak, J. Woo, V. Liu, and C. Lee Effect of dominant negative transforming growth factor-beta receptor type II on cytotoxic activity of RAW 264.7, a murine macrophage cell line Cancer Res 67 2007 6717 6724
29. R.M. Palmer, D.S. Ashton, and S. Moncada Vascular endothelial cells synthesize nitric oxide from l-arginine Nature 333 1988 664 666
30. Y. Liu, F. Jiao, Y. Qiu, W. Li, Y. Qu, and C. Tian Immunostimulatory properties and enhanced TNF-alpha mediated cellular immunity for tumor therapy by C60(OH)20 nanoparticles Nanotechnology 20 2009 415102
31. R. Farias-Eisner, F.D. Cirisano, D. Grouse, R.S. Leuchter, B.Y. Karlan, and L.D. Lagasse Conservative and individualized surgery for early squamous carcinoma of the vulva: the treatment of choice for stage I and II (T1-2N0-1M0) disease Gynecol Oncol 53 1994 55 58
32. L. Gorelik, Y. Bar-Dagan, and M.B. Mokyr Insight into the mechanism(s) through which TNF promotes the generation of T cell-mediated antitumor cytotoxicity by tumor bearer splenic cells J Immunol 156 1996 4298 4308
33. M. Miettinen, A. Lehtonen, I. Julkunen, and S. Matikainen Lactobacilli and Streptococci activate NF-kappa B and STAT signaling pathways in human macrophages J Immunol 164 2000 3733 3740
34. E.B. Kopp, and S. Ghosh NF-kappa B and rel proteins in innate immunity Adv Immunol 58 1995 1 27
35. C.M. Olson, M.N. Hedrick, H. Izadi, T.C. Bates, E.R. Olivera, and J. Anguita p38 mitogen-activated protein kinase controls NF-kappaB transcriptional activation and tumor necrosis factor alpha production through RelA phosphorylation mediated by mitogen- and stress-activated protein kinase 1 in response to Borrelia burgdorferi antigens Infect Immun 75 2007 270 277
36. M.C. Berenbaum Immunosuppressive agents Br Med Bull 21 1965 140 146
37. H.C. Maguire Jr., and H.I. Maibach Effect of cyclophosphoramide, 6-mercaptopurine, actinomycin D and vincaleukoblastine on the acquisition of delayed hypersensitivity (DNCB) contact dermatitis in the guinea-pig J Invest Dermatol 37 1961 427 431
38. S.B. Salvin, and R.F. Smith The specificity of allergic reactions. VII. Immunologic unresponsiveness, delayed hypersensitivity, and circulating antibody to proteins and hapten-protein conjugates in adult guinea pigs J Exp Med 119 1964 851 868
39. Y. Chen, J. Tang, X. Wang, F. Sun, and S. Liang An immunostimulatory polysaccharide (SCP-IIa) from the fruit of Schisandra chinensis (Turcz.) Baill Int J Biol Macromol 50 2012 844 848
40. L. Wang, N. Zhao, F. Zhang, W. Yue, and M. Liang Effect of taurine on leucocyte function Eur J Pharmacol 616 2009 275 280
41. Y.X. Mei, H.X. Chen, J. Zhang, X.D. Zhang, and Y.X. Liang Protective effect of chitooligosaccharides against cyclophosphamide-induced immunosuppression in mice Int J Biol Macromol 62 2013 330 335
42. Y. Mizushima, N. Yuhki, M. Hosokawa, and H. Kobayashi Diminution of cyclophosphamide-induced suppression of antitumor immunity by an immunomodulator PS-K and combined therapeutic effects of PS-K and cyclophosphamide on transplanted tumor in rats Cancer Res 42 1982 5176 5180